Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NHI) provides essential updates for stakeholders tracking this healthcare-focused REIT. This page aggregates official announcements and strategic developments related to senior housing financing, medical facility transactions, and operational partnerships.
Investors and analysts will find timely updates on earnings reports, property acquisitions, and joint venture formations, along with regulatory filings and dividend declarations. The curated news flow emphasizes NHI's core activities in sale-leaseback transactions and specialty hospital financing.
Bookmark this page to monitor NHI's progress in capitalizing on aging population trends through its diversified portfolio of assisted living communities, memory care facilities, and skilled nursing properties. Check regularly for insights into how the company balances stable rental income with growth-oriented mezzanine financing strategies.
National Health Investors (NYSE:NHI) reported strong Q4 2024 results with net income per diluted share of $0.95, up from $0.74 year-over-year. The company's NAREIT FFO reached $1.24 per share, while Normalized FFO was $1.12 per share.
Key Q4 highlights include:
- Rental income increased 8.3% ($5.1 million)
- SHOP segment NOI grew 12.5% to $3.2 million
- Completed $237.5 million in new investments during 2024
- Acquired 10 assisted living facilities in North Carolina for $121 million
For 2025, NHI provides guidance of:
- NAREIT FFO: $4.59-$4.66 per share
- Normalized FFO: $4.59-$4.66 per share
- Normalized FAD: $219.8-$223.6 million
The company maintains a strong balance sheet with $1.1 billion in net debt and $331.2 million outstanding on its $700 million revolving credit facility.
National Health Investors (NYSE:NHI) announced the retirement of Robert Webb from its Board of Directors, effective immediately. Webb served on the board for over 34 years since the company's inception in 1991. During his tenure, NHI expanded its healthcare real estate investment and senior housing operating portfolios to exceed $3.0 billion in total gross investments, spanning more than 200 healthcare real estate properties, mortgages, and other notes receivable.
Eric Mendelsohn, NHI President and CEO, acknowledged Webb's instrumental role in the company's growth and extended well wishes for his retirement.
National Health Investors (NYSE:NHI) has announced its schedule for the release of fourth quarter 2024 financial results. The company will release its earnings report after market close on Tuesday, February 25, 2025. Following the release, NHI will host a conference call on Wednesday, February 26, 2025, at 11:00 a.m. Eastern Time to discuss the results.
Investors can join the interactive teleconference by calling (888) 506-0062 with access code 664117. A live broadcast of the conference call will be available online at www.nhireit.com and through a dedicated webcast link. An online replay will be accessible shortly after the call and remain available for one year.
National Health Investors (NYSE:NHI) announced the passing of Joe Wakham, Jr., a 16-year veteran of the company. Wakham served as Controller and Vice President, having joined NHI as an accountant in 2009. Throughout his tenure, he made significant contributions, including developing NHI's supplemental report and leading early IT projects. He was promoted to Assistant Controller in November 2019 and became Controller and Vice President in June 2020.
Beyond his professional role, Wakham was actively involved in community service, serving as an Elder at the North Boulevard Church of Christ and President of BoroDash, a Murfreesboro charitable event.
National Health Investors (NYSE:NHI) announced significant corporate governance changes. Robert A. McCabe, Jr. was appointed as Board Chair following W. Andrew Adams' retirement, while Candice W. Todd joined the Board and will chair the Audit Committee. CEO D. Eric Mendelsohn was named Vice-Chair of the Board.
The company implemented several measures to enhance accountability and transparency, including: appointing Tracy M.J. Colden as Chair of the Nominating Committee, planning to propose removal of the classified board structure at the 2025 annual meeting, creating a Special Committee for master lease negotiations, and establishing an ESG Committee with plans to publish its first sustainability report in Q1 2025.
Since 2020, the Board has expanded from four to eight directors, increasing female representation from 0% to 37.5%. The average Board tenure decreased from 21 to 11 years, while maintaining an average age of approximately 70 years.
National Health Investors (NYSE:NHI) has appointed Candice Todd to its Board of Directors, effective January 1, 2025. Todd previously served as Managing Director/Global Chief Financial Officer of Morgan Stanley Real Estate Investments from 2019 until February 2023. She brings extensive experience in real estate investment and finance, having worked at Morgan Stanley since 1994 in various roles. Todd currently serves on the Board of Directors at Highwoods Properties (NYSE:HIW) as a financial expert and audit committee member. NHI's CEO Eric Mendelson expects her expertise to contribute to the company's internal and external growth objectives.
National Health Investors (NYSE:NHI) announced that W. Andrew 'Andy' Adams will retire as Chairman of the Board effective December 31, 2024, after more than 30 years of leadership. Adams founded the company in 1991 and served as President until February 2009 and CEO until March 2011. Under his leadership, the company has grown its healthcare real estate investment and senior housing operating portfolios to over $3.0 billion in total gross investments across 193 healthcare real estate properties, mortgages and other notes receivable.
National Health Investors (NYSE:NHI) has declared its fourth quarter dividend of $0.90 per common share. The dividend will be paid on January 29, 2025, to stockholders of record as of December 31, 2024.
National Health Investors (NYSE: NHI), a real estate investment trust, has issued an investor update. The company, incorporated in 1991, specializes in sale-leasebacks, joint ventures, senior housing operating partnerships, and mortgage and mezzanine financing for senior housing and medical investments. NHI's portfolio includes independent living, assisted living, memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. The full investor update can be found at NHI's website under Presentations and Webcasts.
National Health Investors (NYSE:NHI) reported Q3 2024 results with net income per diluted share of $0.65, down from $0.68 in Q3 2023. Normalized FFO per share was $1.03, compared to $1.08 year-over-year. The company updated its 2024 guidance, revising NAREIT FFO to $4.39-$4.41 from $4.50-$4.54, primarily due to lower cash lease revenue and interest income assumptions.
Notable developments include $205.6 million in new investments in 2024 with an 8.4% average initial yield, and signed LOIs for another $59.8 million with an 8.8% average yield. The SHOP portfolio showed improvement with quarterly occupancy increasing 960 basis points year-over-year to 88.6%, and NOI increasing 30.4% year-over-year.
FAQ
What is the current stock price of National Health Investors (NHI)?
What is the market cap of National Health Investors (NHI)?
